pharma · Hepatitis B · Bacterial Infections
Green Valley (Shanghai) Pharmaceuticals Co.,
Green Valley Pharmaceutical drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Portfolio lens on 6 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Green Valley Pharmaceutical drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Antiinfectives for systemic use (J07) compound in Green Valley Pharmaceutical's portfolio.
Antiinfectives for systemic use (J06) compound in Green Valley Pharmaceutical's portfolio. Mechanism: Replacement therapy, immunomodulatory effects.
Antiinfectives for systemic use (J07) compound in Green Valley Pharmaceutical's portfolio. Mechanism: Biological vaccine - induces immune response.
Antiinfectives for systemic use (J07) compound in Green Valley Pharmaceutical's portfolio.
Antiinfectives for systemic use (J07) compound in Green Valley Pharmaceutical's portfolio.
Development asset linked to Green Valley Pharmaceutical in public FDA and regional records.